Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Lucid Diagnostics Inc (LUCD) PT Lowered to $2 at Cantor Fitzgerald
November 15, 2024 6:41 AM ESTCantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $2.00 (from $3.00) while maintaining a Overweight rating.
The analyst comments "We are lowering our price target to $2 from $3 as the company is still working through the process of receiving... More
